Cargando…
Erratum: Mcl-1 Inhibition: Managing Malignancy in Multiple Myeloma
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8438299/ https://www.ncbi.nlm.nih.gov/pubmed/34531757 http://dx.doi.org/10.3389/fphar.2021.758130 |
_version_ | 1783752341469528064 |
---|---|
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-8438299 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-84382992021-09-15 Erratum: Mcl-1 Inhibition: Managing Malignancy in Multiple Myeloma Front Pharmacol Pharmacology Frontiers Media S.A. 2021-08-31 /pmc/articles/PMC8438299/ /pubmed/34531757 http://dx.doi.org/10.3389/fphar.2021.758130 Text en Copyright © 2021 Frontiers Production Office. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Pharmacology Erratum: Mcl-1 Inhibition: Managing Malignancy in Multiple Myeloma |
title | Erratum: Mcl-1 Inhibition: Managing Malignancy in Multiple Myeloma |
title_full | Erratum: Mcl-1 Inhibition: Managing Malignancy in Multiple Myeloma |
title_fullStr | Erratum: Mcl-1 Inhibition: Managing Malignancy in Multiple Myeloma |
title_full_unstemmed | Erratum: Mcl-1 Inhibition: Managing Malignancy in Multiple Myeloma |
title_short | Erratum: Mcl-1 Inhibition: Managing Malignancy in Multiple Myeloma |
title_sort | erratum: mcl-1 inhibition: managing malignancy in multiple myeloma |
topic | Pharmacology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8438299/ https://www.ncbi.nlm.nih.gov/pubmed/34531757 http://dx.doi.org/10.3389/fphar.2021.758130 |
work_keys_str_mv | AT erratummcl1inhibitionmanagingmalignancyinmultiplemyeloma |